Group-integrated Cognitive Behavioural Therapy (Gi-CBT) to Aid Communities' Reintegration of Former Terrorists in Nigeria: A Randomised Control Trial
Launched by TEESSIDE UNIVERSITY · Nov 28, 2022
Trial Information
Current as of January 14, 2025
Unknown status
Keywords
ClinConnect Summary
The main question it aims to answer are:
• What is the feasibility in terms of recruitment, retention, adherence to the intervention and communities/victims' satisfaction with Gi-CBT to promote healing and improve the successful reintegration of of former Boko Haram terrorists' members and their families.into society?
Participants will be randomly allocated into two groups. The first group, the intervention group, will receive the Group integrated Cognitive Behavioural Therapy (Gi-CBT). The second group will receive government intervention involving media messages from the National Orient...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. community members who had previous experience of trauma as a result of Boko Haram atrocities, score 5 and above for the culturally-adapted Trauma Screening Questionnaire (Brewinn et al., 2002)
- • 2. are aged 18+ years and above
- • 3. are residents of the designated areas including Bornu (Maiduguri), and its environs.
- Exclusion Criteria:
- • those not meeting the study inclusion criteria will be excluded.
About Teesside University
Teesside University is a leading higher education institution dedicated to advancing research and innovation in various fields, including healthcare and clinical studies. With a strong emphasis on collaboration and community engagement, the university fosters a dynamic environment for clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Through its state-of-the-art facilities and a multidisciplinary team of researchers, Teesside University actively supports the development and implementation of cutting-edge clinical research initiatives, ensuring adherence to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials